ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.

[1]  G. Wolterink,et al.  Behavioral and neurotrophic activity of ACTH-(7-16)NH2. , 1989, Life sciences.

[2]  T. Chiu,et al.  Interactions of ACTH4–10 and ACTH1–24 with L-[3H] glutamate binding sites and GABA/benzodiazepine/picrotoxin receptor complexes in vitro , 1988, Brain and Development.

[3]  A. Eberle.  The Melanotropins: Chemistry, Physiology and Mechanisms of Action , 1988 .

[4]  D. Manallack,et al.  A Three Dimensional Receptor Model of the Dopamine D2 Receptor from Computer Graphic Analyses of D2 Agonists , 1988, The Journal of pharmacy and pharmacology.

[5]  G. Wolterink,et al.  Structure‐Activity Studies on the Neuroactive and Neurotropic Effects of Neuropeptides Related to ACTH , 1988, Annals of the New York Academy of Sciences.

[6]  J. Hinson,et al.  ACTH and adrenal aerobic glycolysis. I: Effects of O-nitrophenylsulphenyl and other ACTH analogues, vasoactive intestinal peptide and human parathyroid hormone(1-34) on lactic acid, steroid and cyclic AMP production by mouse adrenocortical cells. , 1987, The Journal of endocrinology.

[7]  M. Vugt,et al.  In vitro interaction of ACTH with rat brain muscarinic receptors , 1986, Peptides.

[8]  D. Versteeg,et al.  ACTH-(1-24) and alpha-MSH antagonize dopamine receptor-mediated inhibition of striatal dopamine and acetylcholine release. , 1986, Life sciences.

[9]  A. Cools,et al.  Dopaminergic modulation of ACTH-induced grooming. , 1986, European journal of pharmacology.

[10]  W. Gispen,et al.  ACTH and signal transduction in the neuronal membrane , 1986 .

[11]  W. Gispen,et al.  Excessive grooming in response to ACTH , 1986 .

[12]  W. Gispen,et al.  Phosphoprotein B-50: localization and function. , 1986, Progress in brain research.

[13]  S. Peroutka.  Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brain , 1985, Brain Research.

[14]  A. Barnett,et al.  Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. , 1984, Life sciences.

[15]  J. Frost,et al.  Cortisol production by dispersed guinea-pig adrenal cells; a specific, sensitive and reproducible response to ACTH....and its fragments. , 1984, Journal of steroid biochemistry.

[16]  B. Wolfe,et al.  Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. , 1984, The Journal of pharmacology and experimental therapeutics.

[17]  G. Kovacs,et al.  Sites of behavioral and neurochemical action of ACTH-like peptides and neurohypophyseal hormones , 1983, Neuroscience & Biobehavioral Reviews.

[18]  B. Bohus.  Opiomelanocortins and behavioral adaptation. , 1984, Pharmacology & therapeutics.

[19]  R. Schwyzer,et al.  Liposome‐mediated labeling of adrenocorticotropin fragments parallels their biological activity , 1983, FEBS letters.

[20]  J. Jolles,et al.  Neuromodulation by ACTH: A role for membrane phosphorylation , 1983 .

[21]  W. Gispen,et al.  The effect of ACTH on rat brain synaptic plasma membrane lipid fluidity. , 1982, Biochimica et biophysica acta.

[22]  J. Jolles,et al.  Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. , 1982, Physiological reviews.

[23]  J. W. Nispen,et al.  Structure-activity relationships of peptides derived from ACTH, β-LPH and MSH with regard to avoidance behavior in rats , 1982 .

[24]  M. Shinitzky,et al.  The modulation of protein phosphorylation and receptor binding in synaptic membranes by changes in lipid fluidity: implications for ageing. , 1982, Progress in brain research.

[25]  J. Palacios,et al.  [3H]Spiperone binding sites in brain: autoradiographic localization of multiple receptors , 1981, Brain Research.

[26]  J. Leysen,et al.  Optimal Conditions for [3H]Apomorphine Binding and Anomalous Equilibrium Binding of [3H]Apomorphine and [3H]Spiperone to Rat Striatal Membranes: Involvement of Surface Phenomena Versus Multiple Binding Sites , 1981, Journal of neurochemistry.

[27]  N. Ling,et al.  ‘γ-MSH’ fragments from ACTH-β-LPH precursor have an affinity for opiate receptors , 1980 .

[28]  H. Akil,et al.  Binding of 3H-beta-endorphin to rat brain membranes: characterization of opiate properties and interaction with ACTH. , 1980, European journal of pharmacology.

[29]  R. Olson,et al.  Behavioral effects of melanocyte stimulating hormone , 1980, Neuroscience & Biobehavioral Reviews.

[30]  D. Versteeg,et al.  Interaction of peptides related to ACTH, MSH and beta-LPH with neurotransmitters in the brain. , 1980, Pharmacology and Therapeutics.

[31]  I. Creese,et al.  3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptors. , 1979, European journal of pharmacology.

[32]  S. Snyder,et al.  Histamine H1-receptors in brain labeled with 3H-mepyramine. , 1978, European journal of pharmacology.

[33]  R. Schwyzer,et al.  ACTH: A SHORT INTRODUCTORY REVIEW * , 1977, Annals of the New York Academy of Sciences.

[34]  C. McMartin,et al.  Differences between in-vitro and in-vivo potencies of corticotrophins: an interpretation in terms of metabolic stability. , 1977, The Journal of endocrinology.

[35]  P. Seeman,et al.  Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Gispen,et al.  Interaction between ACTH fragments, brain opiate receptors and morphine-induced analgesia. , 1976, European journal of pharmacology.

[37]  W. Gispen,et al.  ACTH-like peptides and opiate receptors in the rat brain: structure-activity studies. , 1975, European journal of pharmacology.

[38]  S. Snyder,et al.  Muscarinic cholinergic binding in rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Hofmann,et al.  ACTH antagonists. , 1974, Proceedings of the National Academy of Sciences of the United States of America.